Sheng Kang

701 total citations
28 papers, 495 citations indexed

About

Sheng Kang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Sheng Kang has authored 28 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Sheng Kang's work include Cardiovascular Function and Risk Factors (5 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Coronary Interventions and Diagnostics (5 papers). Sheng Kang is often cited by papers focused on Cardiovascular Function and Risk Factors (5 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Coronary Interventions and Diagnostics (5 papers). Sheng Kang collaborates with scholars based in China, United States and Italy. Sheng Kang's co-authors include Yuejin Yang, Xian Li, Yangfeng Wu, Chongjian Li, Zhongmin Liu, Runlin Gao, Lieying Fan, Jue Li, Huimin Fan and Zhang Dai-fu and has published in prestigious journals such as PLoS ONE, European Heart Journal and Atherosclerosis.

In The Last Decade

Sheng Kang

27 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Kang China 14 259 147 87 85 83 28 495
Johannes Törnig Germany 14 396 1.5× 122 0.8× 97 1.1× 160 1.9× 105 1.3× 17 946
Günter Stein Germany 7 206 0.8× 141 1.0× 51 0.6× 150 1.8× 71 0.9× 8 704
Jun Irita Japan 16 298 1.2× 161 1.1× 99 1.1× 150 1.8× 141 1.7× 32 746
H.‐P. Schultheiss Germany 9 380 1.5× 183 1.2× 154 1.8× 56 0.7× 60 0.7× 14 735
Ayako Nagumo Japan 13 416 1.6× 151 1.0× 82 0.9× 74 0.9× 120 1.4× 21 602
Daijiro Enomoto Japan 14 268 1.0× 111 0.8× 122 1.4× 156 1.8× 75 0.9× 44 617
Farzad Ziai United States 13 169 0.7× 89 0.6× 85 1.0× 72 0.8× 78 0.9× 14 640
Han Wu China 14 176 0.7× 143 1.0× 179 2.1× 109 1.3× 70 0.8× 49 624
P. Roesen Germany 10 379 1.5× 148 1.0× 75 0.9× 126 1.5× 147 1.8× 18 703
Rodolfo Nasti Italy 9 126 0.5× 100 0.7× 134 1.5× 53 0.6× 115 1.4× 14 422

Countries citing papers authored by Sheng Kang

Since Specialization
Citations

This map shows the geographic impact of Sheng Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Kang more than expected).

Fields of papers citing papers by Sheng Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Kang. The network helps show where Sheng Kang may publish in the future.

Co-authorship network of co-authors of Sheng Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Kang. A scholar is included among the top collaborators of Sheng Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Kang. Sheng Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Wei, et al.. (2023). Insights into lipid metabolism and immune-inflammatory responses in the pathogenesis of coronary artery ectasia. Frontiers in Physiology. 14. 1096991–1096991. 5 indexed citations
2.
Zhou, Jian, Bingyu Li, Sheng Kang, et al.. (2021). The Association of Left Atrial Appendage Morphology to Atrial Fibrillation Recurrence After Radiofrequency Ablation. Frontiers in Cardiovascular Medicine. 8. 677885–677885. 7 indexed citations
4.
Kang, Qi, Lujin Li, Xiangdong Li, et al.. (2015). Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury. PLoS ONE. 10(3). e0119846–e0119846. 22 indexed citations
5.
Kang, Sheng, Ping Yu, Shanshan Yu, et al.. (2015). Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure. Journal of Translational Medicine. 13(1). 44–44. 14 indexed citations
6.
Zhang, Lijuan, Zisheng Ai, Liling Zou, et al.. (2012). Association between risk factors and left ventricular remodeling in middle-aged and aged population. Journal of Hypertension. 30(9). 1862–1873. 6 indexed citations
7.
Zhang, Haitao, et al.. (2011). No-reflow disrupts the expression and distribution of Connexin 43 in a swine model. Microvascular Research. 82(3). 404–409. 2 indexed citations
8.
Kang, Sheng, Yuejin Yang, Yiling Wu, et al.. (2010). Expression of FLK1 and CD146 at day 7 following reperfused acute myocardial infarction. Cytotherapy. 13(3). 304–307.
9.
Kang, Sheng, Yuejin Yang, Yiling Wu, et al.. (2009). Myocardium and microvessel endothelium apoptosis at day 7 following reperfused acute myocardial infarction. Microvascular Research. 79(1). 70–79. 15 indexed citations
11.
Kang, Sheng, et al.. (2009). Expressions of eNOS3 and Ve-Cadherin in Microvascular Endothelium at 7-Day of Reperfused Acute Myocardial Infarction. Cardiovascular & Haematological Disorders - Drug Targets. 9(2). 107–117. 3 indexed citations
12.
Kang, Sheng, Yuejin Yang, Chongjian Li, & Runlin Gao. (2008). Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coronary Artery Disease. 19(5). 327–335. 39 indexed citations
13.
Yang, Yuejin, Sheng Kang, Bo Xu, et al.. (2008). Short- and long-term outcomes of single bare metal stent versus drug eluting stent in nondiabetic patients with a simple de novo lesion in the middle and large vessel. Journal of Translational Medicine. 6(1). 42–42. 5 indexed citations
15.
Zhao, Xueyan, Jian Zhang, Aimin Dang, et al.. (2006). [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].. PubMed. 86(17). 1165–9. 3 indexed citations
16.
Kang, Sheng, Yuejin Yang, Bo Xu, et al.. (2006). Comparison of drug eluting stents with bare metal stents in daily practice for bifurcation lesions in Chinese patients. Chinese Medical Journal. 119(14). 1157–1164. 6 indexed citations
17.
Lü, Min, et al.. (2004). [Hypertension and subclinical carotid atherosclerosis in a general population of a rural areas in China].. PubMed. 25(10). 841–4. 1 indexed citations
18.
Lü, Min, et al.. (2004). Hypertension and subclinical carotid atherosclerosis in a suburban general population in China. Journal of Hypertension. 22(9). 1699–1706. 18 indexed citations
19.
Kang, Sheng, Yangfeng Wu, & Xian Li. (2004). Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 177(2). 433–442. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026